Real life experience with ceftolozane-tazobactam in tertiary hospital

被引：0
|
作者：
Sadyrbaeva-Dolgova, S. [1 ]
Guijarro-Herrera, S. [1 ]
Cancela-Diez, B. [1 ]
Garcia-Fumero, R. [1 ]
Jimenez-Morales, A. [1 ]
机构：
[1] Hosp Univ Virgen Ias Nieves, Granada, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2020年 / 42卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PT042
引用
下载
收藏
页码：289 / 290
页数：2
相关论文
共 50 条
  • [21] Drug resistance rates of difficult to treat Pseudomonas aeruginosa isolates to ceftolozane-tazobactam and ceftazidime-avibactam from a tertiary hospital, Singapore
    Leong, Queenie
    Chew, Ka Lip
    PATHOLOGY, 2022, 54 (07) : 966 - 968
  • [22] A Real-world Multicenter Outpatient Experience of Ceftolozane/Tazobactam
    Van Anglen, Lucinda J.
    Schroeder, Claudia P.
    Couch, Kimberly A.
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (05):
  • [23] Evaluation of ceftolozane-tazobactam susceptibility on a French nationwide collection of Enterobacterales
    Jousset, Agnes B.
    Bernabeu, Sandrine
    Emeraud, Cecile
    Bonnin, Remy A.
    Lomont, Alexandra
    Zahar, Jean Ralph
    Merens, Audrey
    Isnard, Christophe
    Soismier, Nathalie
    Farfour, Eric
    Fihman, Vincent
    Yin, Nicolas
    Barraud, Olivier
    Jacquier, Herve
    Ranc, Anne-Gaelle
    Laurent, Frederic
    Corvec, Stephane
    d'Epenoux, Louise Ruffier
    Bille, Emmanuelle
    Degand, Nicolas
    Plouzeau, Chloe
    Guillard, Thomas
    Cattoir, Vincent
    Mizrahi, Asaf
    Grillon, Antoine
    Janvier, Frederic
    Le Brun, Cecile
    Amara, Marlene
    Bastide, Mathilda
    Lemonnier, Alban
    Dortet, Laurent
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 78 - 84
  • [24] Ceftolozane-tazobactam versus levofloxacin in urinary tract infection Reply
    Wagenlehner, Florian M.
    Umeh, Obiamiwe
    Darouiche, Rabih O.
    LANCET, 2015, 386 (10000): : 1242 - 1242
  • [25] Ceftolozane-Tazobactam utilization in the national veterans affairs healthcare system
    Cusumano, Jaclyn A.
    Bodo, Emily
    Lopes, Vrishali
    McConeghy, Kevin W.
    Puzniak, Laura A.
    McCann, Eilish
    LaPlante, Kerry L.
    Caffrey, Aisling R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 508 - 509
  • [26] Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa
    Barnes, Melissa D.
    Taracila, Magdalena A.
    Rutter, Joseph D.
    Bethel, Christopher R.
    Galdadas, Ioannis
    Hujer, Andrea M.
    Caselli, Emilia
    Prati, Fabio
    Dekker, John P.
    Papp-Wallace, Krisztina M.
    Haider, Shozeb
    Bonomo, Robert A.
    MBIO, 2018, 9 (06):
  • [27] Use of Ceftazidime-Avibactam and Ceftolozane-Tazobactam After Lung Transplantation
    Amore, Davide
    Pecoraro, Ylenia
    Carillo, Carolina
    Russo, Gianluca
    Poggi, Camilla
    Anile, Marco
    Pagini, Andreina
    Bassi, Massimiliano
    Cagnetti, Sara
    Mottola, Emilia
    D'Agostino, Federica Gilda
    Vannucci, Jacopo
    Mantovani, Sara
    Pugliese, Francesco
    De Giacomo, Tiziano
    Rendina, Erino Angelo
    Venuta, Federico
    Diso, Daniele
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (05) : 1605 - 1607
  • [28] Failure of ceftolozane-tazobactam salvage therapy in complicated pneumonia with lung abscess
    Lewis, Paul O.
    Cluck, David B.
    Tharp, Jennifer L.
    Krolikowski, Matthew A.
    Patel, Paras D.
    CLINICAL CASE REPORTS, 2018, 6 (07): : 1308 - 1312
  • [29] Ceftolozane-Tazobactam Pharmacokinetics in a Critically Ill Patient on Continuous Venovenous Hemofiltration
    Oliver, Wesley D.
    Heil, Emily L.
    Gonzales, Jeffrey P.
    Mehrotra, Shailly
    Robinett, Kathryn
    Saleeb, Paul
    Nicolau, David P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1899 - 1901
  • [30] Pharmacokinetics of Ceftolozane-Tazobactam during Prolonged Intermittent Renal Replacement Therapy
    Rawlins, Matthew
    Cheng, Vesa
    Raby, Edward
    Dyer, John
    Regli, Adrian
    Ingram, Paul
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Roberts, Jason A.
    CHEMOTHERAPY, 2018, 63 (04) : 203 - 206
12345